Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1 1

Status

Terminated 2Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3

Conditions

Neurofibromatosis 1 3Breast Neoplasms 3Melanoma 2Squamous Cell Carcinoma of Head and Neck 1Radiation Injuries 1Prostatic Neoplasms 1Precancerous Conditions 1Ovarian Neoplasms 1Oropharyngeal Neoplasms 1Noonan Syndrome 1Nasopharyngeal Carcinoma 1Mouth Neoplasms 1Learning Disabilities 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Dyslexia 1Cognition Disorders 1Carcinoma, Ovarian Epithelial 1Carcinoma 1Breast Carcinoma In Situ 1

Interventions

Trastuzumab 304Paclitaxel 257Cyclophosphamide 251Docetaxel 238Capecitabine 176Letrozole 163Carboplatin 163Fulvestrant 145Doxorubicin 145Bevacizumab 121Anastrozole 106Tamoxifen 102exemestane 94Vinorelbine 91Epirubicin 90pertuzumab 89Gemcitabine 84Lapatinib 80Albumin-Bound Paclitaxel 74Radiotherapy 71pembrolizumab 70palbociclib 64130-nm albumin-bound paclitaxel 58eribulin 56Cisplatin 55Everolimus 49pyrotinib 45Taxes 44Goserelin 43Neoadjuvant Therapy 40

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Breast Neoplasms × Lovastatin × Clear all
NCT07619365 2026-06-02

Trastuzumab Deruxtecan and Lovastatin in HER2-low and Ultralow Advanced or Metastatic Breast Cancer

Washington University School of Medicine

Phase 2 Not yet recruiting
60 enrolled
Breast

Breast Neoplasms

NCT00285857 2017-03-09

Phase 2 Study of Lovastatin as Breast Cancer Chemoprevention

Stanford University

Phase 2 Terminated
30 enrolled 7 charts
Breast

Breast Neoplasms

NCT00902668 2013-06-20

Lovastatin in Reducing Side Effects After Radiation Therapy in Women With Breast Cancer

Virginia Commonwealth University

Phase 2 Terminated
3 enrolled 4 charts
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Radiation Injuries

Data powered by HemOnc (CC BY 4.0) Colophon âš¡